JP2022529579A5 - - Google Patents

Info

Publication number
JP2022529579A5
JP2022529579A5 JP2021557827A JP2021557827A JP2022529579A5 JP 2022529579 A5 JP2022529579 A5 JP 2022529579A5 JP 2021557827 A JP2021557827 A JP 2021557827A JP 2021557827 A JP2021557827 A JP 2021557827A JP 2022529579 A5 JP2022529579 A5 JP 2022529579A5
Authority
JP
Japan
Prior art keywords
composition according
silicon
phosphatidylcholine
manufacture
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021557827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022529579A (ja
JP7637416B2 (ja
Filing date
Publication date
Priority claimed from GBGB1904337.1A external-priority patent/GB201904337D0/en
Application filed filed Critical
Publication of JP2022529579A publication Critical patent/JP2022529579A/ja
Publication of JP2022529579A5 publication Critical patent/JP2022529579A5/ja
Priority to JP2024158947A priority Critical patent/JP7784754B2/ja
Application granted granted Critical
Publication of JP7637416B2 publication Critical patent/JP7637416B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021557827A 2019-03-28 2020-03-30 ケイ素ナノ粒子を含む送達システム Active JP7637416B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024158947A JP7784754B2 (ja) 2019-03-28 2024-09-13 ケイ素ナノ粒子を含む送達システム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1904337.1 2019-03-28
GBGB1904337.1A GB201904337D0 (en) 2019-03-28 2019-03-28 A delivery system
PCT/GB2020/050854 WO2020193999A1 (en) 2019-03-28 2020-03-30 A delivery system comprising silicon nanoparticles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024158947A Division JP7784754B2 (ja) 2019-03-28 2024-09-13 ケイ素ナノ粒子を含む送達システム

Publications (3)

Publication Number Publication Date
JP2022529579A JP2022529579A (ja) 2022-06-23
JP2022529579A5 true JP2022529579A5 (https=) 2023-10-30
JP7637416B2 JP7637416B2 (ja) 2025-02-28

Family

ID=66442849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021557827A Active JP7637416B2 (ja) 2019-03-28 2020-03-30 ケイ素ナノ粒子を含む送達システム
JP2024158947A Active JP7784754B2 (ja) 2019-03-28 2024-09-13 ケイ素ナノ粒子を含む送達システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024158947A Active JP7784754B2 (ja) 2019-03-28 2024-09-13 ケイ素ナノ粒子を含む送達システム

Country Status (8)

Country Link
US (2) US12496278B2 (https=)
EP (1) EP3946280A1 (https=)
JP (2) JP7637416B2 (https=)
CN (2) CN117398362A (https=)
AU (1) AU2020249810B2 (https=)
CA (1) CA3133117C (https=)
GB (1) GB201904337D0 (https=)
WO (1) WO2020193999A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022132196A (ja) * 2021-02-26 2022-09-07 ナノ ターゲティング アンド セラピー バイオファーマ インコーポレイテッド 薬剤を後眼部に送達するための方法およびその使用
GB202110645D0 (en) * 2021-07-23 2021-09-08 Sisaf Ltd Protection of biological molecules from degradation
GB202110644D0 (en) * 2021-07-23 2021-09-08 Sisaf Ltd Improved nucleic acid vector particles
GB202110646D0 (en) * 2021-07-23 2021-09-08 Sisaf Ltd Nucleic acid vector compositions
CN121622565A (zh) * 2022-05-16 2026-03-10 苏州维益生物科技有限公司 纳米颗粒、其制备和应用、及包括其的眼疾药物及其制备
GB202210794D0 (en) 2022-07-22 2022-09-07 Sisaf Ltd Lipid formulations
GB202300914D0 (en) * 2023-01-20 2023-03-08 Sisaf Ltd Manufacturing process
GB202300915D0 (en) * 2023-01-20 2023-03-08 Sisaf Ltd mRNA COMPOSITIONS
GB202300911D0 (en) * 2023-01-20 2023-03-08 Sisaf Ltd Therapeutic compositions and methods
GB202300912D0 (en) * 2023-01-20 2023-03-08 Sisaf Ltd Therapeutic compostions and methods
CN116473928B (zh) * 2023-03-01 2024-06-14 东北师范大学 精氨酸/磷酸钙纳米粒子的制备方法及其应用

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175531B1 (da) 1986-12-15 2004-11-22 Nexstar Pharmaceuticals Inc Leveringsvehikel med amphiphil-associeret aktiv bestanddel
NL9400189A (nl) 1994-02-07 1995-09-01 Bio Pharma Sciences Bv Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat.
CN1227482A (zh) 1996-06-27 1999-09-01 普罗克特和甘保尔公司 化妆品组合物
FR2799758B1 (fr) 1999-10-15 2002-05-17 Exsymol Sa Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation
GB0104383D0 (en) 2001-02-22 2001-04-11 Psimedica Ltd Cancer Treatment
US6670335B2 (en) 2001-03-05 2003-12-30 A. P. Pharma, Inc. Fluorouracil-containing formulation
EP1391426A1 (en) 2002-08-12 2004-02-25 Bio Minerals N.V. Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
JP2006016390A (ja) 2004-06-04 2006-01-19 Toyo Shinyaku:Kk プロアントシアニジン含有組成物
CN1981044B (zh) * 2004-06-07 2010-05-05 普洛体维生物治疗公司 包封干扰rna的脂质
ES2669585T3 (es) 2004-10-29 2018-05-28 The Regents Of The University Of California Micropartículas porosas de silicio para la entrega de fármaco para el ojo
CN101277704A (zh) * 2005-04-12 2008-10-01 因特拉迪格姆公司 用于治疗癌症及其它新血管生成疾病的RNAi治疗剂的组合物和方法
GB0515353D0 (en) 2005-07-27 2005-08-31 Psimedica Ltd Food
US8920821B2 (en) 2006-04-14 2014-12-30 Perrigo Israel Pharmaceuticals Ltd. Pharmaceutical compositions comprising silica microspheres
US7696866B2 (en) 2007-06-28 2010-04-13 Microsoft Corporation Learning and reasoning about the context-sensitive reliability of sensors
KR20160021307A (ko) * 2007-07-10 2016-02-24 더 리전트 오브 더 유니버시티 오브 캘리포니아 선택된 조직에 조성물을 전달하는 물질 및 방법
US20090053268A1 (en) 2007-08-22 2009-02-26 Depablo Juan J Nanoparticle modified lubricants and waxes with enhanced properties
EP2030632A1 (en) 2007-09-03 2009-03-04 UMC Utrecht Holding B.V. A carrier particle for use in bio-applications
GB0817936D0 (en) 2008-09-30 2008-11-05 Intrinsiq Materials Global Ltd Porous materials
IT1394656B1 (it) 2009-07-03 2012-07-05 Brev Angela Srl Processo per la produzione e l'assemblaggio di una siringa per operazioni medicali
GB0913255D0 (en) 2009-07-30 2009-09-02 Sisaf Ltd Topical composition
JP2011032194A (ja) 2009-07-31 2011-02-17 Kracie Home Products Ltd 油中水型乳化化粧料
US8992984B1 (en) 2009-10-21 2015-03-31 Stc.Unm Protocells and their use for targeted delivery of multicomponent cargos to cancer cells
ES2385080B1 (es) * 2010-12-21 2013-05-10 Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea Nanopartículas lipídicas para el tratamiento de enfermedades oculares.
EP2765997A4 (en) 2011-10-14 2015-06-24 Stc Unm POROUS NANOPARTICLE-SUPPORTED LIPID DOUBLE LAYERS (PROTOCOLS) FOR THE TARGETED RELEASE BY TRANSDERMAL RELEASE AND USE METHOD THEREFOR
US9096679B2 (en) * 2012-12-03 2015-08-04 The Board Of Regents Of The University Of Oklahoma Peptide compounds and methods of production and use thereof
EP2968571A4 (en) 2013-03-15 2016-09-07 Psivida Inc BIODEGRADABLE SILICONE BASED COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS
US20170165375A1 (en) 2013-04-02 2017-06-15 Stc. Unm Antibiotic protocells and related pharmaceutical formulations and methods of treatment
JP2016521568A (ja) 2013-06-12 2016-07-25 ユニヴェルシテ・ドゥ・ナミュールUniversite de Namur 生細胞の冷凍保存
EP3470089A1 (en) * 2013-12-12 2019-04-17 The Broad Institute Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
GB201402669D0 (en) 2014-02-14 2014-04-02 Medical Res Council Stabilised silicate compositions and their uses
EP2946793A1 (en) * 2014-05-23 2015-11-25 Universitat Rovira I Virgili Silicon particles targeting tumor cells
CN104127886A (zh) 2014-07-16 2014-11-05 上海理工大学 一种CpG核酸药物输送系统及其制备方法
CN105434205A (zh) 2014-11-08 2016-03-30 马南行 一种眼部快速弹开皱纹延缓衰老的组合物及其制备方法
CN114533898B (zh) * 2015-07-09 2025-07-01 加利福尼亚大学董事会 融合脂质体包被的多孔硅纳米颗粒
LU92784B1 (en) 2015-07-22 2017-01-31 Luxembourg Inst Of Science And Tech (List) Negatively charged self-assembling supported lipid bilayer on mesoporous silica nanoparticles, method of synthesis and use as a nanovector
WO2017040976A1 (en) * 2015-09-02 2017-03-09 Erkki Ruoslahti Compounds and compositions for targeting brain injuries and methods of use thereof
US20180344641A1 (en) 2015-09-04 2018-12-06 C. Jeffrey Brinker Mesoporous silica nanoparticles and supported lipid bi-layer nanoparticles for biomedical applications
US20190262469A1 (en) 2015-09-04 2019-08-29 C. Jeffrey Brinker Protocells to treat microbial infection and for synergistic delivery
JP7384512B2 (ja) * 2015-10-22 2023-11-21 モデルナティエックス インコーポレイテッド 広域インフルエンザウイルスワクチン
EP4218739A3 (en) 2016-01-08 2023-08-09 The Regents of The University of California Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
WO2017181115A1 (en) * 2016-04-14 2017-10-19 Spinnaker Biosciences, Inc. Porous silicon materials comprising a metal silicate for delivery of therapeutic agents
CN106177982A (zh) 2016-07-26 2016-12-07 上海应用技术学院 一种透明质酸修饰的脂质介孔硅核壳纳米组装体及其制备方法
JP7510254B2 (ja) 2016-08-10 2024-07-03 ユナイテッド キングダム リサーチ アンド イノベーション ナノシリカ粒子を含む組成物および療法のためにtリンパ球を活性化する方法におけるそれらの使用
CN106265432A (zh) 2016-08-30 2017-01-04 钟治超 一种含有薄荷精油的美白美容乳剂
LU100023B1 (en) 2017-01-20 2018-07-30 Luxembourg Inst Science & Tech List Nanocapsules and method for manufacturing thereof
CN106806343B (zh) 2017-02-17 2020-10-13 清华大学深圳研究生院 一种叶酸和聚多巴胺修饰的肿瘤靶向介孔二氧化硅纳米粒及制备方法与应用
US20200261580A1 (en) 2017-07-17 2020-08-20 Andrea Willey Photodynamic Therapy Method for Skin Disorders
US20200375912A1 (en) 2017-08-03 2020-12-03 Rita Elena Serda Liposomal coated nanoparticles for immunotherapy applications
CN107625966A (zh) 2017-09-10 2018-01-26 河南工业大学 一种自组装式脂质‑介孔硅核/壳复合型纳米药物载体及其制备方法
CN107616952A (zh) 2017-10-31 2018-01-23 广州赛莱拉干细胞科技股份有限公司 一种含菊花细胞提取物的祛皱护肤组合物及其制备方法
CN107998264A (zh) 2018-01-15 2018-05-08 福建傲农生物科技集团股份有限公司 一种治疗猪呼吸道疾病的中西药复方超微粉剂及其制备方法与应用
CN108552223A (zh) 2018-01-17 2018-09-21 天津市植物保护研究所 一种含芽胞杆菌的液体菌悬剂及其应用

Similar Documents

Publication Publication Date Title
JP2022529579A5 (https=)
JP2024169482A5 (https=)
Tawfik et al. Nanomedicine and drug delivery to the retina: current status and implications for gene therapy
F Fangueiro et al. Ocular drug delivery-new strategies for targeting anterior and posterior segments of the eye
JP7026507B2 (ja) 眼において薬物徐放を達成する方法及び生体適合性組成物
Puglia et al. Lipid nanocarriers (LNC) and their applications in ocular drug delivery
Raj et al. Ocular drug delivery system: challenges and approaches
Bravo-Osuna et al. Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases
US20170157038A1 (en) Ophthalmic drug delivery method
JP2017061467A5 (https=)
Amrutkar et al. Nanocarriers for ocular drug delivery: recent advances and future opportunities
Shivhare et al. An update review on novel advanced ocular drug delivery system
JP2024534570A5 (https=)
Zhang et al. Intractable ocular diseases and treatment progress
US10272035B2 (en) Ophthalmic drug delivery method
Vishal et al. Current status and advanced approaches in ocular drug delivery system
Hajare et al. A rational approach to ocular drug delivery systems: A overview
Amrite et al. Nanoparticles for ocular drug delivery
Pignatello et al. Nanotechnology in ophthalmic drug delivery: a survey of recent developments and patenting activity
Jani et al. Ocular Drug Delivery Systems
Rawat et al. Nanotechnology advancements in treating ocular infectious diseases: a paradigm shift in therapeutic strategies
Bennett Topical versus systemic ocular drug delivery
Herrero-Vanrell et al. Ocular pharmacokinetic drug, bioavailability and intraocular drug delivery systems
Arora et al. Ophthalmic drug delivery system—A concise review on its conventional and novel approaches
Bhanu Malhotra et al. Ocular drug delivery systems.